The scientist’s investigation covers issues in Immunology, Acquired immunodeficiency syndrome, Virology, Viral disease and Obstetrics. His study in Immunology is interdisciplinary in nature, drawing from both MEDLINE and Antiretroviral therapy. In Acquired immunodeficiency syndrome, F. de Wolf works on issues like Internal medicine, which are connected to HIV Wasting Syndrome.
His Virology study combines topics in areas such as T cell, Asymptomatic and Antigen. His Viral disease research is multidisciplinary, relying on both Antibody and Immunopathology. His studies in Obstetrics integrate themes in fields like Pregnancy, Preeclampsia, Placental site trophoblastic tumor and Decidua.
F. de Wolf focuses on Immunology, Virology, Acquired immunodeficiency syndrome, Viral disease and Internal medicine. His work on Immunology is being expanded to include thematically relevant topics such as Cytotoxic T cell. His Virology research integrates issues from Peripheral blood mononuclear cell and Antibody, Serology.
His research on Acquired immunodeficiency syndrome also deals with topics like
F. de Wolf mainly investigates Antiretroviral therapy, Internal medicine, Immunology, Acquired immunodeficiency syndrome and Pediatrics. His studies deal with areas such as Hiv infected, Physical therapy, Viral disease and Virology as well as Antiretroviral therapy. His Internal medicine research is multidisciplinary, relying on both Hepatitis C virus and Immunodeficiency.
His research in Immunology is mostly focused on Viral load. His work on Cd4 cell count as part of general Acquired immunodeficiency syndrome study is frequently linked to Presentation, therefore connecting diverse disciplines of science. His work carried out in the field of Pediatrics brings together such families of science as Developed country, Hiv infected patients, Prospective cohort study and Cohort study.
F. de Wolf focuses on Immunology, Viral load, Acquired immunodeficiency syndrome, Lower limit and Hiv 1 rna. F. de Wolf integrates many fields in his works, including Immunology and Presentation. His Viral load research incorporates elements of Cohort study, Hazard ratio, Confidence interval, Survival analysis and Pediatrics.
His work deals with themes such as Public health surveillance and Incidence, which intersect with Acquired immunodeficiency syndrome. His Lower limit investigation overlaps with other disciplines such as Plasma viral load, Sensitivity analyses and Racial group.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants.
T. Y. Khong;F. De Wolf;W. B. Robertson;I. Brosens.
British Journal of Obstetrics and Gynaecology (1986)
Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
M. Tersmette;R. A. Gruters;F. De Wolf;R. E. Y. De Goede.
Journal of Virology (1989)
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
M. Tersmette;J. M. Lange;R. E. de Goede;F. de Wolf.
The Lancet (1989)
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation
Nadine G. Pakker;Daan W. Notermans;Rob J. De Boer;Marijke T.L. Roos.
Nature Medicine (1998)
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
F Miedema;A J Petit;F G Terpstra;J K Schattenkerk.
Journal of Clinical Investigation (1988)
Late presentation of HIV infection: a consensus definition
A Antinori;T Coenen;D Costagiola;N Dedes.
Hiv Medicine (2011)
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
J. M. A. Lange;D. A. Paul;H. G. Huisman;F. De Wolf.
BMJ (1986)
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
H. Schuitemaker;N. A. Kootstra;R. E. Y. De Goede;F. De Wolf.
Journal of Virology (1991)
Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection
A.M. de Roda Husman;M. Koot;M.T.E. Cornelissen;I.P.M. Keet.
Annals of Internal Medicine (1997)
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
G Chêne;J A C Sterne;M May;D Costagliola.
The Lancet (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
University of Amsterdam
University of Amsterdam
Sorbonne University
University of Amsterdam
University of Bristol
University of Bordeaux
Simon Fraser University
University of Bristol
University of Amsterdam
Institut Laue-Langevin
Xi'an Jiaotong University
National Institute for Materials Science
University of Cambridge
University of Santiago de Compostela
United States Department of Agriculture
Field Museum of Natural History
National Center for Toxicological Research
University of Southern California
Royal Holloway University of London
University of California, Los Angeles
Johannes Gutenberg University of Mainz
Grenoble Alpes University
University of Minnesota
University of Nebraska Medical Center
École Polytechnique Fédérale de Lausanne